Mounjaro sales force?

Quote






Former Lily rap here who left and went to amgen. What I would tell you is this is all dependent on who your manager is. Your pay will be substantially lower at Lily and your bonuses at 100% quota are $26,000 per year. You can only do 10 meals per customer per year and are expected to make 8.5 calls per day. You will most likely have a team of one to two other reps selling injectables plus you'll have two other reps selling the non-injectable diabetes medicines. In order to overcome the 10 meals per year limit you're going to do a lot of lunches with your teammates. In fact, you will do a lot of calls together with teammates in order to get your call per day requirement hit. The company is a very left-leaning organization with tons of diversity equity and inclusion initiatives. They have great Healthcare and maternity leave policies. 6% 401k match and pension.
 






anonymous said:
Former Lily rap here who left and went to amgen. What I would tell you is this is all dependent on who your manager is. Your pay will be substantially lower at Lily and your bonuses at 100% quota are $26,000 per year. You can only do 10 meals per customer per year and are expected to make 8.5 calls per day. You will most likely have a team of one to two other reps selling injectables plus you'll have two other reps selling the non-injectable diabetes medicines. In order to overcome the 10 meals per year limit you're going to do a lot of lunches with your teammates. In fact, you will do a lot of calls together with teammates in order to get your call per day requirement hit. The company is a very left-leaning organization with tons of diversity equity and inclusion initiatives. They have great Healthcare and maternity leave policies. 6% 401k match and pension.
Click to expand...

100% nailed it!
I will add that your $6000 per Q bonus before taxes is not solely based on your performance either. Mounjaro bonuses are paid out basexon how your entire district performs.
Oh you’re #1 in the country with Mounjaro? Well if your district doesn’t hit the district goal then it doesn’t matter how well you do lol.
Oh did I mention that your bonus is capped at 120%?yes that’s right. If your district lit the world on fire then you could make a whole $7000 before taxes that quarter.
I’m sure the 100 million speaker programs that you were doing & the required breakfast & lunch everyday would be worth that HUGE payout .. well if those district of 10 people hit their goals at 120% lol
 






Current Mounjaro rep. As of this week our district is at 100% goal with only ~6 weeks of selling since launch. More room to grow with the obesity trial showing weightloss equivalent to bariatric surgery. True, bonus is capped at 120% but that number is ~$10K per quarter pre-tax. I've been in pharma long enough to know when I have a good product. Mounjaro will sell itself. Just pass go and collect $200.
 












anonymous said:
Current Mounjaro rep. As of this week our district is at 100% goal with only ~6 weeks of selling since launch. More room to grow with the obesity trial showing weightloss equivalent to bariatric surgery. True, bonus is capped at 120% but that number is ~$10K per quarter pre-tax. I've been in pharma long enough to know when I have a good product. Mounjaro will sell itself. Just pass go and collect $200.
Click to expand...

$25 no questions asked is what is selling Moubjaro in my POD. It doesn’t sell itself without the cash coupon.
Once that coupon expires, let’s see how we are doing.
 






anonymous said:
$25 no questions asked is what is selling Moubjaro in my POD. It doesn’t sell itself without the cash coupon.
Once that coupon expires, let’s see how we are doing.
Click to expand...


Same. Bypassing all PAs for $25 is HUGE.
MJ will sell itself though in GLP heavy markets.
Not all markets are first injection friendly.

To the other poster. 120% to goal of $6,500 is $7,800 not $10k lol

And that is BEFORE taxes.

Enjoy your TRX goals in 2 quarters after everyone has been switched from TR & OZ & you’re relying off NBRX only & can’t replicate the growth from switches.
 






Mounjari is not easily tolerated. My HCPs already have patients calling in throwing their guts up. They are moving them back to OZ because their is more doses to adjust with their pen
 






anonymous said:
Same. Bypassing all PAs for $25 is HUGE.
MJ will sell itself though in GLP heavy markets.
Not all markets are first injection friendly.

To the other poster. 120% to goal of $6,500 is $7,800 not $10k lol

And that is BEFORE taxes.

Enjoy your TRX goals in 2 quarters after everyone has been switched from TR & OZ & you’re relying off NBRX only & can’t replicate the growth from switches.
Click to expand...


Better be careful with that. I have several offices that have scripts coming back from the co-pay card that is still requiring PAs. They are already pushing back and its not just a few either.
I’ve got some offices that are pissed because they wrote so many and now they are getting tons of call backs on PAs
 






anonymous said:
Mounjari is not easily tolerated. My HCPs already have patients calling in throwing their guts up. They are moving them back to OZ because their is more doses to adjust with their pen
Click to expand...
Bahhh ha ha!!!
Novo rep? Oz and novo are screwed, MJ will take over the entire market. Funny-they like the Oz pen…..funny
 






anonymous said:
Better be careful with that. I have several offices that have scripts coming back from the co-pay card that is still requiring PAs. They are already pushing back and its not just a few either.
I’ve got some offices that are pissed because they wrote so many and now they are getting tons of call backs on PAs
Click to expand...
this happened with emgality, and will be a problem come July 2023 . It’s not rejecting on the coupon YET, and they’re mad because they’re getting pa requests and you said it’s $25


until it’s approved, anybody using it for weight loss and requiring a PA will most likely be denied , and denied again on appeal .

see Cigna -

Conditions Not Covered
Tirzepatide (MounjaroTM) is considered experimental, investigational or unproven for ANY other use including the following (this list may not be all inclusive):
1. Weight Loss. Mounjaro is not FDA approved for weight loss in an individual without type 2 diabetes. Clinical trials in individuals with overweight or obesity are ongoing. Note: If the individual has type 2 diabetes, refer to FDA-Approved Indication.
2. Type 1 Diabetes Mellitus. Mounjaro is not indicated for type 1 diabetes, and these individuals were excluded from clinical trials.

when this happens, there won’t be any alternatives covered by insurance , other than if they meet the criteria for Saxenda or Wegovy , which will be difficult if they’ve already lost the weight and haven’t been enrolled in a weight management program or tried phentermine

so it’s a clusterf*** about to happen , but make the most out of it while you can
 






anonymous said:
Better be careful with that. I have several offices that have scripts coming back from the co-pay card that is still requiring PAs. They are already pushing back and its not just a few either.
I’ve got some offices that are pissed because they wrote so many and now they are getting tons of call backs on PAs
Click to expand...


tell them to send it to Kroger or cvs :/
 


















Rep from another non competing company here - taking MJ for weight loss. Doing so well on it 25 lbs down 30 more to go. Rumors are that the copay card will no longer work after Oct 3rd unless you are type2 Diabetic. I understand why this is happening but is it new patients only or all patients (are we grandfathered in until June 2023?)? Thanks in advance, I don’t want to have to stop MJ it has helped my inflammation so much besides the weight loss.
 






anonymous said:
Same. Bypassing all PAs for $25 is HUGE.
MJ will sell itself though in GLP heavy markets.
Not all markets are first injection friendly.

To the other poster. 120% to goal of $6,500 is $7,800 not $10k lol

And that is BEFORE taxes.

Enjoy your TRX goals in 2 quarters after everyone has been switched from TR & OZ & you’re relying off NBRX only & can’t replicate the growth from switches.
Click to expand...


Okay noisy Nelly, apparently you can’t read or skipped the kickoff meeting, 120% performance is a 200% payout, look it up, that is $10k+ for PC and $12k+ for spec. per quarter. My district is going to probably hit max payout in both quarters. Best chance to bank some payout $$$ in a long time.
 












anonymous said:
Bahhh ha ha!!!
Novo rep? Oz and novo are screwed, MJ will take over the entire market. Funny-they like the Oz pen…..funny
Click to expand...
Too many of us selling this. Wait a couple years and all of those side effects that didn’t happen in the clinical trial will appear. Lilly sucks! Yes, it’s new, but in a year I’ll be sick of selling it with my pod mates.
 












PC1 rep here.
The changes & restrictions to the MJ co-pay card are having a major negative impact on my territory.
My HCPs are cutting way back on new prescriptions because the can’t write it for weight loss any more. I’ve had a couple tell me they are concerned about being fraudulent if they write for anything other than T2D now.
I hope I don’t get goals based off of my launch or I won’t get paid… at all.
 






Top Bottom
Back
Quote